Search research articles
Contact Us
Filters
Showing results (61-70 of 66) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 66 results.
Blood
|
May 31, 2002
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution
Suparno Chakrabarti, Stephen Mackinnon, Raj Chopra, et al.
Leukemia
|
June 20, 2021
Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies
Andrea G S Pepper, Antonella Zucchetto, Kevin Norris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2020
Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia
Alexey V Danilov, Charles Herbaux, Harriet S Walter, et al.
Blood
|
January 29, 2021
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target
Emma Kennedy, Eve Coulter, Emma Halliwell, et al.
Leukemia
|
June 20, 2021
Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length
Eileen M Boyle, Louis Williams, Patrick Blaney, et al.
Haematologica
|
October 5, 2019
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia
Jared A Cohen, Francesca Maria Rossi, Antonella Zucchetto, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 66) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 66 results.
Blood
|
May 31, 2002
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution
Suparno Chakrabarti, Stephen Mackinnon, Raj Chopra, et al.
Leukemia
|
June 20, 2021
Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies
Andrea G S Pepper, Antonella Zucchetto, Kevin Norris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2020
Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia
Alexey V Danilov, Charles Herbaux, Harriet S Walter, et al.
Blood
|
January 29, 2021
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target
Emma Kennedy, Eve Coulter, Emma Halliwell, et al.
Leukemia
|
June 20, 2021
Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length
Eileen M Boyle, Louis Williams, Patrick Blaney, et al.
Haematologica
|
October 5, 2019
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia
Jared A Cohen, Francesca Maria Rossi, Antonella Zucchetto, et al.
Page
of 7